Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice

Documenti analoghi

• Transgenic expression of non-structural genes of Theiler’s virus suppresses initial viral replication and pathogenesis of demyelination
  di: Kang, Hyun Seok, et al.
  Pubblicazione: (2016)
• The Level of Viral Infection of Antigen-Presenting Cells Correlates with the Level of Development of Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
  di: Jin, Young Hee, et al.
  Pubblicazione: (2014)
• Epitope-Specific CD8(+) T Cells Play a Differential Pathogenic Role in the Development of a Viral Disease Model for Multiple Sclerosis
  di: Myoung, Jinjong, et al.
  Pubblicazione: (2012)
• A Spontaneous Low-Pathogenic Variant of Theiler’s Virus Contains an Amino Acid Substitution within the Predominant VP1(233–250) T-Cell Epitope
  di: Kim, Byung S., et al.
  Pubblicazione: (1998)
• CD154 Blockade Results in Transient Reduction in Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
  di: Howard, Laurence M., et al.
  Pubblicazione: (2003)